EP3139937A4 - Angiogenesemodulationszusammensetzungen mit verzögerter freisetzung und verfahren zur induktion und modulation von angiogenese - Google Patents

Angiogenesemodulationszusammensetzungen mit verzögerter freisetzung und verfahren zur induktion und modulation von angiogenese Download PDF

Info

Publication number
EP3139937A4
EP3139937A4 EP15789993.1A EP15789993A EP3139937A4 EP 3139937 A4 EP3139937 A4 EP 3139937A4 EP 15789993 A EP15789993 A EP 15789993A EP 3139937 A4 EP3139937 A4 EP 3139937A4
Authority
EP
European Patent Office
Prior art keywords
angiogenesis
induction
modulation
methods
sustained release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP15789993.1A
Other languages
English (en)
French (fr)
Other versions
EP3139937A1 (de
Inventor
Peter S. MCFETRIDGE
Marc C. MOORE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida Research Foundation Inc
Original Assignee
University of Florida Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida Research Foundation Inc filed Critical University of Florida Research Foundation Inc
Publication of EP3139937A1 publication Critical patent/EP3139937A1/de
Publication of EP3139937A4 publication Critical patent/EP3139937A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3808—Endothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP15789993.1A 2014-05-08 2015-05-07 Angiogenesemodulationszusammensetzungen mit verzögerter freisetzung und verfahren zur induktion und modulation von angiogenese Withdrawn EP3139937A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461990256P 2014-05-08 2014-05-08
PCT/US2015/029666 WO2015171880A1 (en) 2014-05-08 2015-05-07 Sustained release angiogenesis modulating compositions and methods for induction and modulation of angiogenesis

Publications (2)

Publication Number Publication Date
EP3139937A1 EP3139937A1 (de) 2017-03-15
EP3139937A4 true EP3139937A4 (de) 2017-12-27

Family

ID=54392991

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15789993.1A Withdrawn EP3139937A4 (de) 2014-05-08 2015-05-07 Angiogenesemodulationszusammensetzungen mit verzögerter freisetzung und verfahren zur induktion und modulation von angiogenese

Country Status (6)

Country Link
EP (1) EP3139937A4 (de)
JP (1) JP2017520517A (de)
KR (1) KR20160147055A (de)
AU (1) AU2015255907A1 (de)
CA (1) CA2948348A1 (de)
WO (1) WO2015171880A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210369630A1 (en) * 2018-10-17 2021-12-02 University Of Florida Research Foundation Magnetically responsive composite microparticles for triggered delivery of biologically active agents

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218065A2 (de) * 1985-08-30 1987-04-15 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Wiederhergestellter Basalmembrankomplex mit biologischer Aktivität
US20080131522A1 (en) * 2006-10-03 2008-06-05 Qing Liu Use of placental biomaterial for ocular surgery
US20130195992A1 (en) * 2005-09-27 2013-08-01 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994559A (en) * 1985-12-17 1991-02-19 Synergen, Inc. Human basic fibroblast growth factor
JP2770926B2 (ja) * 1985-12-17 1998-07-02 サイナーゲン インコーポレーテッド 毛管内皮細胞プロテアーゼ合成、ｄｎａ合成および遊走を促進することの出来るヒト胎盤血管形成誘導因子
JPS63152322A (ja) * 1986-09-30 1988-06-24 Ichimaru Pharcos Co Ltd プラセンタ−組織由来フイブロネクチン含有溶液
JPH0931100A (ja) * 1995-07-24 1997-02-04 Nippon Ham Kk 変性コラーゲン及びその製造方法
US7775965B2 (en) * 2004-03-09 2010-08-17 The Board Of Regents Of The University Of Oklahoma Decellularized grafts from umbilical cord vessels and process for preparing and using same
CN101316602B (zh) * 2005-09-27 2015-06-03 组织技术公司 羊膜制品和纯化的组合物及其使用方法
WO2012096796A1 (en) * 2011-01-10 2012-07-19 Stemnion, Inc. Methods for accelerating the healing of connective tissue injuries and disorders

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218065A2 (de) * 1985-08-30 1987-04-15 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Wiederhergestellter Basalmembrankomplex mit biologischer Aktivität
US20130195992A1 (en) * 2005-09-27 2013-08-01 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US20080131522A1 (en) * 2006-10-03 2008-06-05 Qing Liu Use of placental biomaterial for ocular surgery

Also Published As

Publication number Publication date
WO2015171880A1 (en) 2015-11-12
KR20160147055A (ko) 2016-12-21
JP2017520517A (ja) 2017-07-27
AU2015255907A1 (en) 2016-12-01
EP3139937A1 (de) 2017-03-15
CA2948348A1 (en) 2015-11-12

Similar Documents

Publication Publication Date Title
IL273058A (en) Compositions and methods for modulation of PKK expression
AU2015370664B2 (en) Immune modulation
EP3139957A4 (de) Zusammensetzungen und verfahren zur modulation von wachstumsfaktoren
AU2015370664A1 (en) Immune modulation
EP3218483A4 (de) Verbindungen und verfahren zur modulation von proteinen
EP3137596A4 (de) Zusammensetzungen und verfahren zur modulation der expression vom komplementfaktor b
EP3151846A4 (de) Verfahren und zusammensetzungen zur nukleasekonstruktion
EP3096759A4 (de) Formulierungen aus pridopidin mit modifizierter freisetzung
EP3307782A4 (de) Verfahren und antikörper zur modulation von immunreaktionen
EP3139943A4 (de) Kombinationen aus nmdar-modulierenden verbindungen
EP3154561A4 (de) Modulation der komplementaktivität
EP3092763A4 (de) Kombinierte amplituden-zeit-modulation und phasenmodulation
IL264216A (en) Compounds and Methods for Modulating SMN2
EP3131723A4 (de) Modulation der thixotropen eigenschaften von zementmaterialien
EP3226859A4 (de) Zusammensetzungen und verfahren zur modulation von s-nitrosylierung
EP3096757A4 (de) Apilimodzusammensetzungen und verfahren zur verwendung davon
EP3094323A4 (de) Verfahren und zusammensetzungen zur modulierung von hormonspiegeln
EP3149049A4 (de) Modulation von zellulärem stress
EP3107567A4 (de) Verfahren zur modulierung einer immunreaktion
EP3099443A4 (de) Induktionsvorrichtungen und verfahren zur verwendung davon
ZA201700495B (en) Signaling of modulation configuration
EP3137624A4 (de) Zusammensetzungen und verfahren zur modulierung von mtorc1
AU2017219901B2 (en) Methods of immunogenic modulation
EP3197558A4 (de) Zusammensetzungen und verfahren zur transienten immunantwortmodulation während der impfung
EP3220940A4 (de) Zusammensetzungen und verfahren zur modulierung der at2r-aktivität

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20161206

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20171129

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/50 20150101AFI20171123BHEP

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1235305

Country of ref document: HK

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20190116

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20191203

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1235305

Country of ref document: HK